83 related articles for article (PubMed ID: 14960239)
1. [Relationship between expression of hyaluronan and pathologic features of ovarian adenocarcinoma].
Qu JY; Li S; Lin H; Wu JB; Wang YQ
Ai Zheng; 2004 Feb; 23(2):177-80. PubMed ID: 14960239
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas.
Afify AM; Ferguson AW; Davila RM; Werness BA
Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):309-14. PubMed ID: 11759056
[TBL] [Abstract][Full Text] [Related]
3. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer.
Anttila MA; Tammi RH; Tammi MI; Syrjänen KJ; Saarikoski SV; Kosma VM
Cancer Res; 2000 Jan; 60(1):150-5. PubMed ID: 10646867
[TBL] [Abstract][Full Text] [Related]
4. CD44 expression indicates favorable prognosis in epithelial ovarian cancer.
Sillanpää S; Anttila MA; Voutilainen K; Tammi RH; Tammi MI; Saarikoski SV; Kosma VM
Clin Cancer Res; 2003 Nov; 9(14):5318-24. PubMed ID: 14614016
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
Afify AM; Stern R; Michael CW
Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
[TBL] [Abstract][Full Text] [Related]
6. Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis.
Köbel M; Weichert W; Crüwell K; Schmitt WD; Lautenschläger C; Hauptmann S
Virchows Arch; 2004 Nov; 445(5):456-64. PubMed ID: 15375658
[TBL] [Abstract][Full Text] [Related]
7. High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer.
Lipponen P; Aaltomaa S; Tammi R; Tammi M; Agren U; Kosma VM
Eur J Cancer; 2001 May; 37(7):849-56. PubMed ID: 11313172
[TBL] [Abstract][Full Text] [Related]
8. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
Afify AM; Craig S; Paulino AF; Stern R
Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan and its receptors in mucoepidermoid carcinoma.
Wein RO; McGary CT; Doerr TD; Popat SR; Howard JL; Weigel JA; Weigel PH
Head Neck; 2006 Feb; 28(2):176-81. PubMed ID: 16355387
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD44s, CD44v6, and hyaluronan across the spectrum of normal-hyperplasia-carcinoma in breast.
Afify A; McNiel MA; Braggin J; Bailey H; Paulino AF
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):121-7. PubMed ID: 18227732
[TBL] [Abstract][Full Text] [Related]
11. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
Afify A; Lynne LC; Howell L
Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan expression in differentiated thyroid carcinoma.
Böhm J; Niskanen L; Tammi R; Tammi M; Eskelinen M; Pirinen R; Hollmen S; Alhava E; Kosma VM
J Pathol; 2002 Feb; 196(2):180-5. PubMed ID: 11793369
[TBL] [Abstract][Full Text] [Related]
13. Detection of a specific pattern of hyaluronan oligosaccharides and their binding proteins in human ovarian tumour.
Kolapalli SP; Nunna V; Thomas A; Mortha KK; Banerjee SD; Boregowda RK
Cell Biochem Funct; 2016 Jun; 34(4):217-25. PubMed ID: 27001487
[TBL] [Abstract][Full Text] [Related]
14. Decreased CD44 expression and stromal hyaluronate accumulation in myxoid dermatofibroma.
Calikoglu E; Chavaz P; Saurat JH; Kaya G
Dermatology; 2003; 207(1):104-6. PubMed ID: 12835568
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44.
Cao JJ; Singleton PA; Majumdar S; Boudignon B; Burghardt A; Kurimoto P; Wronski TJ; Bourguignon LY; Halloran BP
J Bone Miner Res; 2005 Jan; 20(1):30-40. PubMed ID: 15619667
[TBL] [Abstract][Full Text] [Related]
16. Strong Stromal Hyaluronan Expression Is Associated with PSA Recurrence in Local Prostate Cancer.
Aaltomaa S; Lipponen P; Tammi R; Tammi M; Viitanen J; Kankkunen JP; Kosma VM
Urol Int; 2002; 69(4):266-72. PubMed ID: 12444281
[TBL] [Abstract][Full Text] [Related]
17. Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival.
Kayastha S; Freedman AN; Piver MS; Mukkamalla J; Romero-Guittierez M; Werness BA
Clin Cancer Res; 1999 May; 5(5):1073-6. PubMed ID: 10353740
[TBL] [Abstract][Full Text] [Related]
18. Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells.
Yeo TK; Nagy JA; Yeo KT; Dvorak HF; Toole BP
Am J Pathol; 1996 Jun; 148(6):1733-40. PubMed ID: 8669459
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronan synthases, hyaluronan, and its CD44 receptor in tissue around loosened total hip prostheses.
Konttinen YT; Li TF; Mandelin J; Ainola M; Lassus J; Virtanen I; Santavirta S; Tammi M; Tammi R
J Pathol; 2001 Jul; 194(3):384-90. PubMed ID: 11439372
[TBL] [Abstract][Full Text] [Related]
20. High CD44 expression on human mesotheliomas mediates association with hyaluronan.
Penno MB; Askin FB; Ma H; Carbone M; Vargas MP; Pass HI
Cancer J Sci Am; 1995; 1(3):196-203. PubMed ID: 9166476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
